Literature DB >> 17197383

Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1.

Lene Martini1, Maria Waldhoer, Margareta Pusch, Viktor Kharazia, Jamie Fong, Josephine H Lee, Clarissa Freissmuth, Jennifer L Whistler.   

Abstract

The cannabinoid 1 receptor (CB1R) is one of the most abundant seven transmembrane (7TM) spanning/G-protein-coupled receptors in the central nervous system and plays an important role in pain transmission, feeding, and the rewarding effects of cannabis. Tolerance to cannabinoids has been widely observed after long-term use, with concomitant receptor desensitization and/or down-regulation depending on the brain region studied. Several CB1R agonists promote receptor internalization after activation, but the postendocytic sorting of the receptor has not been studied in detail. Utilizing human embryonic kidney (HEK293) cells stably expressing the CB1R and primary cultured neurons expressing endogenous CB1R, we show that treatment with cannabinoid agonists results in CB1R degradation after endocytosis and that the G-protein-coupled receptor-associated sorting protein GASP1 plays a major role in the postendocytic sorting process. Thus, these results may identify a molecular mechanism underlying tolerance and receptor down-regulation after long-term use of cannabinoids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17197383     DOI: 10.1096/fj.06-7132com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  63 in total

Review 1.  Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?

Authors:  Tricia H Smith; Laura J Sim-Selley; Dana E Selley
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 2.  Atypical regulation of G protein-coupled receptor intracellular trafficking by ubiquitination.

Authors:  Michael R Dores; JoAnn Trejo
Journal:  Curr Opin Cell Biol       Date:  2013-12-07       Impact factor: 8.382

3.  Molecular Interaction between Distal C-Terminal Domain of the CB1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Proteins (CRIP1a/CRIP1b).

Authors:  Pratishtha Singh; Anjali Ganjiwale; Allyn C Howlett; Sudha M Cowsik
Journal:  J Chem Inf Model       Date:  2019-12-10       Impact factor: 4.956

4.  Dopamine D(3) receptors are down-regulated following heterologous endocytosis by a specific interaction with G protein-coupled receptor-associated sorting protein-1.

Authors:  Dawn Thompson; Jennifer L Whistler
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

Review 5.  Molecular model of cannabis sensitivity in developing neuronal circuits.

Authors:  Erik Keimpema; Ken Mackie; Tibor Harkany
Journal:  Trends Pharmacol Sci       Date:  2011-07-13       Impact factor: 14.819

Review 6.  Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences.

Authors:  J M McPartland; M Glass; R G Pertwee
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

Review 7.  Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors.

Authors:  M M Rosenkilde; M J Smit; M Waldhoer
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

8.  Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling.

Authors:  Christine Börner; Michal Smida; Volker Höllt; Burkhart Schraven; Jürgen Kraus
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

9.  Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A.

Authors:  Richard J Ward; John D Pediani; Graeme Milligan
Journal:  J Biol Chem       Date:  2011-09-09       Impact factor: 5.157

10.  ΔFosB induction correlates inversely with CB₁ receptor desensitization in a brain region-dependent manner following repeated Δ⁹-THC administration.

Authors:  Matthew F Lazenka; Dana E Selley; Laura J Sim-Selley
Journal:  Neuropharmacology       Date:  2013-09-30       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.